BioSpace News Archive

The Curie Institute is a worldwide renowned center engaged leader in fundamental and applied scientific research to better serve humankind in fighting illnesses such as cancer.

This amendment approval from Health Canada will facilitate the study and permit achieving the required sample size in a timely manner.

Portage Biotech Inc., (NASDAQ: PRTG) (“Portage” or the “Company”) a clinical-stage immuno-oncology company focused on the development of therapies targeting cancer treatment resistance, today announced that the Company has been added to the Russell 2000 Index at the conclusion of the 2021 Russell Indexes annual reconstitution, effective after the U.S. market opened on June 28.

Konica Minolta Healthcare Americas, Inc. announced an agreement with Mercury Medical as the company’s distributor for ultrasound solutions in the anesthesia market.

CrestOptics S.p.A., today announced that it has been selected by Akoya Biosciences Inc., (Nasdaq: AKYA) The Spatial Biology Company®, as a premier microscope provider to jointly develop new spatial biology and spatial phenotyping applications.

The market growth is mainly attributed to the increasing adoption rate of modeling tools in drug discovery and rising investments for drug discovery.

Results from two large clinical trials show significant and early benefits from sotagliflozin, a drug that inhibits sodium-glucose transport protein 2 and sodium-glucose transport protein 1 in reducing heart failure, heart attack, and stroke—major problems in people with diabetes.

Yield10 Bioscience, Inc. today announced two new hires. Tichafa Munyikwa, Ph.D. has been appointed Director of Regulatory Affairs.

Selexis SA and KBI Biopharma announced today that they have signed service agreements with Immatics N.V. (NASDAQ: IMTX; “Immatics”), a clinical-stage biopharmaceutical company active in the discovery and development of T cell redirecting cancer immunotherapies.

Cannex Scientific Inc., a biopharmaceutical company focused on therapeutic discoveries in the area of cannabinoid medicine, announced it has entered into a sponsored research agreement with Brigham and Women’s Hospital.